Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |